S&P 500
5,961.07
-0.2%
-$9.74
DJI
42,473.24
+0.1%
+$45.50
NASDAQ
19,382.11
-0.4%
-$78.38
Bitcoin
103,043.00
-1.9%
-2,009.05
AAPL
$202.23
-0.3%
-$0.59
AMZN
$209.52
+1.1%
+$2.29
GOOG
$171.02
+1.0%
+$1.63
META
$687.69
-0.0%
-$0.26
MSFT
$469.44
+1.2%
+$5.57
NVDA
$140.46
-1.0%
-$1.46
TSLA
$286.27
-13.8%
-$45.78
Ignyte Acquisition Corp. (NASDAQ: IGNY)
Some price data may be temporarily unavailable.
Ignyte Acquisition Corp. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ignyte Acquisition Corp. Company Info
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease. The company is headquartered in Palo Alto, CA.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.